Mercaptopurine
- Product NDC
- 71921-150
- 11-digit product format
- 719210150
- Labeler code
- 71921
- Product ID
- 71921-150_e7309808-5ae8-4a55-90e3-3992ace0da62
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Mercaptopurine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Florida Pharmaceutical Products, LLC
- Application
- NDA009053
- Marketing category
- NDA
- Marketing start
- 2026-01-30
- Substance
- MERCAPTOPURINE
- Active strength
- 50 mg/1
- Pharmacologic classes
- Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Mercaptopurine
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| MERCAPTOPURINE | 50 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | E7WED276I5 |
| Rxcui | 197931 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 71921-150-02 | Mercaptopurine | 25 in 1 BOTTLE | TABLET | 25 | | 1 |
| 71921-150-25 | Mercaptopurine | 250 in 1 BOTTLE | TABLET | 250 | | 1 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 71921-150-02 | 71921015002 | 25 TABLET in 1 BOTTLE (71921-150-02) | 25 tablet | 2026-01-30 | No | No | Historical |
| 71921-150-25 | 71921015025 | 250 TABLET in 1 BOTTLE (71921-150-25) | 250 tablet | 2026-01-30 | No | No | Historical |